Donaldson Reports Record Fourth Quarter and Fiscal Year 2024 Sales and Earnings
Fourth Quarter Fiscal 2024 Highlights
(All comparisons against the fourth quarter fiscal 2023 unless otherwise noted)
-
Sales of
$935 million , up 6.4% -
GAAP EPS of
$0.90 , up 20.0%; adjusted EPS of$0.94 -
Returned approximately
$82 million to shareholders through share repurchases and dividends - Announced plans to optimize footprint aimed at increased efficiency
Full Year Fiscal 2024 Highlights
(All comparisons against fiscal year 2023 unless otherwise noted)
-
Sales of
$3.6 billion , up 4.5% -
GAAP EPS of
$3.38 , up 16.6%; adjusted EPS of$3.42 -
Returned approximately
$286 million to shareholders through share repurchases and dividends
Fiscal 2025 Guidance
-
Expect full year fiscal 2025 sales growth of 2% to 6% and adjusted EPS of
$3.56 to$3.72
“In fourth quarter, we delivered an all-time high level of profitability through solid sales and robust margin expansion while continuing to invest for the future, capping off a record year for Donaldson,” said
“For fiscal 2025, we expect to achieve another year of record sales and earnings as we execute on our longer-term strategic initiatives. We are updating our fiscal 2026 financial targets to reflect our continued confidence in delivering strong consolidated profitability while adjusting for market-driven and segment-specific sales and margin trends.”
____________________________
1 |
Fourth quarter 2024, 2023, and full-year 2023 earnings include Restructuring and Other Charges. See Restructuring and Other Charges section for more information. |
2 |
All EPS figures refer to diluted EPS. |
3 |
Adjusted EPS is a non-GAAP financial measure that excludes the impact of certain items not related to ongoing operations. |
Fourth Quarter Operating Results
Sales increased 6.4% to
|
Three Months Ended |
|
Twelve Months Ended |
||||
|
|
|
|
||||
|
Reported %
|
|
Constant
|
|
Reported %
|
|
Constant
|
Mobile Solutions segment |
|
|
|
|
|
|
|
Off-Road |
(13.0)% |
|
(11.7)% |
|
(11.2)% |
|
(11.3)% |
On-Road |
(11.8) |
|
(9.7) |
|
(4.1) |
|
(3.0) |
Aftermarket |
12.6 |
|
13.9 |
|
8.1 |
|
8.2 |
Total Mobile Solutions segment |
6.1 |
|
7.4 |
|
3.5 |
|
3.6 |
|
|
|
|
|
|
|
|
Industrial Solutions segment |
|
|
|
|
|
|
|
Industrial Filtration Solutions |
(1.5) |
|
(0.8) |
|
3.3 |
|
3.2 |
Aerospace and Defense |
39.7 |
|
40.1 |
|
16.0 |
|
15.5 |
Total Industrial Solutions segment |
3.9 |
|
4.6 |
|
5.1 |
|
4.9 |
|
|
|
|
|
|
|
|
Life Sciences segment |
|
|
|
|
|
|
|
Total Life Sciences segment |
20.7 |
|
23.2 |
|
11.5 |
|
11.7 |
|
|
|
|
|
|
|
|
|
6.4% |
|
7.6% |
|
4.5% |
|
4.5% |
|
|
|
|
|
|
|
|
Mobile Solutions segment (Mobile) sales increased 6.1%, resulting from strength in Aftermarket partially offset by Off-Road and On-Road declines. Aftermarket sales grew 12.6%, driven by the lapping of OEM customer destocking in the prior year period as well as improved delivery rates and market share gains in the independent channel. Off-Road sales fell 13.0% as weak agriculture markets persisted in most regions. On-Road sales declined 11.8% due to lower equipment production in
Industrial Solutions segment (Industrial) sales increased 3.9%, driven by robust Aerospace and Defense sales, which rose 39.7% due to strong end-market conditions. Industrial Filtration Solutions (IFS) sales declined 1.5% as weaker dust collection demand in
Life Sciences segment sales increased 20.7% year over year as a result of volume growth in Disk Drive and Food and Beverage.
Gross margin was 35.8%, up 170 basis points from 34.1% in 2023 driven by select input cost deflation and leverage on higher sales. Adjusted gross margin, which excludes the impact from restructuring and other charges, was 36.2%, an increase from 34.3% in 2023.
Operating expenses as a percentage of sales were 20.2%, a 20 basis point improvement from 20.4% in the prior year, resulting from leverage on higher sales. Adjusted operating expenses as a percentage of sales were 19.9% compared with 20.0% in 2023.
Operating income as a percentage of sales (operating margin) of 15.6%, increased 190 basis points year over year from 13.7% in 2023 driven by gross margin expansion and operating expense leverage. Adjusted operating margin was 16.3% compared with 14.3% in the prior year.
Interest expense was
For the full year, Donaldson paid
Full-Year Restructuring and Other Charges
During fourth quarter fiscal 2024, Donaldson incurred
During fourth quarter and full year fiscal 2023, Donaldson incurred
Fiscal 2025 Outlook
Adjusted full-year EPS is expected to be between
Mobile sales are forecast to be flat to up 4% year over year. Off-Road sales are projected to increase low-single digits driven by market share gains. On-Road sales are estimated to decrease low-double digits due to an exit from non-strategic products combined with weak end-market conditions. Aftermarket sales are forecast to increase low-single digits as a result of continued strength in vehicle utilization rates and market share gains.
Industrial sales are expected to grow between 4% and 8% versus 2024. IFS sales are forecast to increase high-single digits with strength across most businesses, including dust collection, Industrial Hydraulics and Industrial Gases. Aerospace and Defense sales are projected to be approximately flat after cycling difficult comparisons in 2024.
Life Sciences sales are forecast to grow low-double digits compared with prior year driven by sales increases in all businesses.
Operating margin is forecast to be between 15.3% and 15.9% versus 15.2%, or 15.4% on an adjusted basis, in 2024 largely driven by sustained gross margin performance.
Interest expense is projected to be approximately
Capital expenditures are forecast to be between
Updated Fiscal 2026 Targets
In view of fiscal 2024 results, combined with an updated performance outlook for fiscal 2025 and 2026, Donaldson is revising its fiscal 2026 financial targets as follows:
|
Current Targets |
Prior Targets |
||
|
(announced at 2023 Investor Day) |
|||
|
FY23 - FY26
|
FY26 Operating Margin |
FY23 - FY26
|
FY26 Operating Margin |
Mobile Solutions |
2% to 6% |
18.1% to 18.9% |
2% to 6% |
15.6% to 16.4% |
|
|
|
|
|
Industrial Solutions |
4% to 8% |
17.8% to 18.6% |
4% to 8% |
16.6% to 17.4% |
|
|
|
|
|
Life Sciences |
12% to 16% |
5% to 11% |
18% to 22% |
22.1% to 22.9% |
|
|
|
|
|
Total |
3% to 7% |
15.8% to 16.6% |
4% to 8% |
15.6% to 16.4% |
Carpenter continued, “In fiscal 2025 and 2026, Mobile and Industrial operating margin strength is forecast to more than offset weaker-than-expected Life Sciences performance. The elongated ramp up in Life Sciences profitability is driven by challenging market conditions and constrained customer capital spending. Overall, we are focused on executing our balanced growth strategy and remain highly confident in our ability to commercialize our innovative technologies and create sustainable long-term value in our Life Sciences business.”
Miscellaneous
The Company will webcast its fourth quarter and full-year 2024 earnings conference call today at
Statements in this release regarding future events and expectations, such as forecasts, plans, trends and projections relating to the Company’s business and financial performance, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are identified by words or phrases such as “will likely result,” “are expected to,” “will continue,” “will allow,” “estimate,” “project,” “believe,” “expect,” “anticipate,” “forecast,” “plan” and similar expressions. These forward-looking statements speak only as of the date such statements are made and are subject to risks and uncertainties that could affect the Company’s performance and could cause the Company’s actual results for future periods to differ materially from any opinions or statements expressed. These factors include, but are not limited to, challenges in global operations; impacts of global economic, industrial and political conditions on product demand; impacts from unexpected events; effects of unavailable raw materials, significant demand fluctuations or material cost changes; inability to attract and retain qualified personnel; inability to meet customer demand; inability to maintain competitive advantages; threats from disruptive technologies; effects of highly competitive markets with pricing pressure; exposure to customer concentration in certain cyclical industries; inability to manage productivity improvements; inability to achieve commitments related to ESG; results of execution of any acquisition, divestiture and other strategic transactions; vulnerabilities associated with information technology systems and security; inability to protect and enforce intellectual property rights; costs associated with governmental laws and regulations; impacts of foreign currency fluctuations; and effects of changes in capital and credit markets. These and other factors are described in Part I, Item 1A, “Risk Factors” of the Company’s Annual Report on Form 10-K for the fiscal year ended
About
Founded in 1915, Donaldson (NYSE: DCI) is a global leader in technology-led filtration products and solutions, serving a broad range of industries and advanced markets. Diverse, skilled employees at over 140 locations on six continents partner with customers - from small business owners to R&D organizations and the world’s biggest OEM brands. Donaldson solves complex filtration challenges through three primary segments: Mobile Solutions, Industrial Solutions and Life Sciences. Additional information is available at www.Donaldson.com.
|
||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS |
||||||||||||||||||||
(In millions, except per share amounts) |
||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||
|
||||||||||||||||||||
|
Three Months Ended |
|
Twelve Months Ended |
|||||||||||||||||
|
|
|
|
|||||||||||||||||
|
|
2024 |
|
|
2023 |
|
|
Change |
|
|
2024 |
|
|
|
2023 |
|
|
Change |
||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Net sales |
$ |
935.4 |
|
$ |
879.5 |
|
|
6.4 |
% |
|
$ |
3,586.3 |
|
|
$ |
3,430.8 |
|
|
4.5 |
% |
Cost of sales |
|
600.6 |
|
|
579.4 |
|
|
3.7 |
|
|
|
2,311.9 |
|
|
|
2,270.2 |
|
|
1.8 |
|
Gross profit |
|
334.8 |
|
|
300.1 |
|
|
11.6 |
|
|
|
1,274.4 |
|
|
|
1,160.6 |
|
|
9.8 |
|
Selling, general and administrative |
|
163.2 |
|
|
157.6 |
|
|
3.6 |
|
|
|
636.7 |
|
|
|
602.3 |
|
|
5.7 |
|
Research and development |
|
25.4 |
|
|
22.0 |
|
|
15.6 |
|
|
|
93.6 |
|
|
|
78.1 |
|
|
19.8 |
|
Operating expenses |
|
188.6 |
|
|
179.6 |
|
|
5.0 |
|
|
|
730.3 |
|
|
|
680.4 |
|
|
7.3 |
|
Operating income |
|
146.2 |
|
|
120.5 |
|
|
21.4 |
|
|
|
544.1 |
|
|
|
480.2 |
|
|
13.3 |
|
Interest expense |
|
5.3 |
|
|
4.9 |
|
|
8.1 |
|
|
|
21.4 |
|
|
|
19.2 |
|
|
11.3 |
|
Other expense (income), net |
|
1.5 |
|
|
(1.7 |
) |
|
NM |
|
|
|
(12.6 |
) |
|
|
(7.7 |
) |
|
62.6 |
|
Earnings before income taxes |
|
139.4 |
|
|
117.3 |
|
|
18.9 |
|
|
|
535.3 |
|
|
|
468.7 |
|
|
14.2 |
|
Income taxes |
|
29.7 |
|
|
25.4 |
|
|
17.0 |
|
|
|
121.3 |
|
|
|
109.9 |
|
|
10.4 |
|
Net earnings |
$ |
109.7 |
|
$ |
91.9 |
|
|
19.4 |
% |
|
$ |
414.0 |
|
|
$ |
358.8 |
|
|
15.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Weighted average shares – basic |
|
120.4 |
|
|
121.4 |
|
|
(0.8 |
)% |
|
|
120.7 |
|
|
|
121.8 |
|
|
(0.9 |
)% |
Weighted average shares – diluted |
|
122.5 |
|
|
123.2 |
|
|
(0.6 |
)% |
|
|
122.6 |
|
|
|
123.6 |
|
|
(0.8 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Net EPS – basic |
$ |
0.91 |
|
$ |
0.76 |
|
|
19.7 |
% |
|
$ |
3.43 |
|
|
$ |
2.95 |
|
|
16.3 |
% |
Net EPS – diluted |
$ |
0.90 |
|
$ |
0.75 |
|
|
20.0 |
% |
|
$ |
3.38 |
|
|
$ |
2.90 |
|
|
16.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Dividends paid per share |
$ |
0.27 |
|
$ |
0.25 |
|
|
8.0 |
% |
|
$ |
1.02 |
|
|
$ |
0.94 |
|
|
8.5 |
% |
Note: Amounts may not foot due to rounding. |
NM = Not meaningful |
|
|||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||
(In millions) |
|||||
(Unaudited) |
|||||
|
|
|
|
||
|
|
|
|
||
|
|
2024 |
|
|
2023 |
Assets |
|
|
|
||
Current assets: |
|
|
|
||
Cash and cash equivalents |
$ |
232.7 |
|
$ |
187.1 |
Accounts receivable, net |
|
629.7 |
|
|
599.7 |
Inventories, net |
|
476.7 |
|
|
418.1 |
Prepaid expenses and other current assets |
|
99.0 |
|
|
81.1 |
Total current assets |
|
1,438.1 |
|
|
1,286.0 |
Property, plant and equipment, net |
|
645.5 |
|
|
652.9 |
|
|
478.4 |
|
|
481.1 |
Intangible assets, net |
|
171.9 |
|
|
188.1 |
Other long-term assets |
|
180.4 |
|
|
162.4 |
Total assets |
$ |
2,914.3 |
|
$ |
2,770.5 |
|
|
|
|
||
Liabilities and Stockholders’ Equity |
|
|
|
||
Current liabilities: |
|
|
|
||
Short-term borrowings |
$ |
28.3 |
|
$ |
34.1 |
Current maturities of long-term debt |
|
25.0 |
|
|
125.0 |
Accounts payable |
|
379.4 |
|
|
304.9 |
Accrued employee compensation and related taxes |
|
140.9 |
|
|
119.4 |
Deferred revenue |
|
19.7 |
|
|
25.3 |
Income taxes payable |
|
42.6 |
|
|
32.3 |
Dividends payable |
|
32.5 |
|
|
30.4 |
Other current liabilities |
|
114.1 |
|
|
85.0 |
Total current liabilities |
|
782.5 |
|
|
756.4 |
Long-term debt |
|
483.4 |
|
|
496.6 |
Non-current income taxes payable |
|
39.8 |
|
|
56.5 |
Deferred income taxes |
|
16.1 |
|
|
32.3 |
Other long-term liabilities |
|
103.4 |
|
|
108.0 |
Total liabilities |
|
1,425.2 |
|
|
1,449.8 |
|
|
|
|
||
Total stockholders’ equity |
|
1,489.1 |
|
|
1,320.7 |
Total liabilities and stockholders’ equity |
$ |
2,914.3 |
|
$ |
2,770.5 |
|
|||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
(In millions) |
|||||||
(Unaudited) |
|||||||
|
|
|
|
||||
|
Twelve Months Ended |
||||||
|
|
||||||
|
|
2024 |
|
|
|
2023 |
|
Operating Activities |
|
|
|
||||
Net earnings |
$ |
414.0 |
|
|
$ |
358.8 |
|
Adjustments to reconcile net earnings to net cash provided by operating activities: |
|
|
|
||||
Depreciation and amortization |
|
98.4 |
|
|
|
92.3 |
|
Deferred income taxes |
|
(24.3 |
) |
|
|
(15.3 |
) |
Stock-based compensation expense |
|
22.0 |
|
|
|
20.4 |
|
Other, net |
|
(1.0 |
) |
|
|
6.3 |
|
Changes in operating assets and liabilities |
|
(16.6 |
) |
|
|
82.0 |
|
Net cash provided by operating activities |
|
492.5 |
|
|
|
544.5 |
|
|
|
|
|
||||
Investing Activities |
|
|
|
||||
Purchases of property, plant and equipment |
|
(85.6 |
) |
|
|
(118.5 |
) |
Proceeds from sale of property, plant and equipment |
|
0.7 |
|
|
|
0.4 |
|
Acquisitions, net of cash acquired |
|
(2.0 |
) |
|
|
(209.2 |
) |
Net cash used in investing activities |
|
(86.9 |
) |
|
|
(327.3 |
) |
|
|
|
|
||||
Financing Activities |
|
|
|
||||
Proceeds from long-term debt |
|
119.7 |
|
|
|
189.2 |
|
Repayments of long-term debt |
|
(228.8 |
) |
|
|
(219.6 |
) |
Change in short-term borrowings |
|
(5.7 |
) |
|
|
30.4 |
|
Purchase of treasury stock |
|
(162.7 |
) |
|
|
(141.8 |
) |
Payment of contingent consideration |
|
(1.7 |
) |
|
|
— |
|
Dividends paid |
|
(122.8 |
) |
|
|
(114.4 |
) |
Tax withholding for stock compensation transactions |
|
(8.0 |
) |
|
|
(4.3 |
) |
Exercise of stock options and other |
|
54.1 |
|
|
|
38.3 |
|
Net cash used in financing activities |
|
(355.9 |
) |
|
|
(222.2 |
) |
Effect of exchange rate changes on cash |
|
(4.1 |
) |
|
|
(1.2 |
) |
Income (decrease) in cash and cash equivalents |
|
45.6 |
|
|
|
(6.2 |
) |
Cash and cash equivalents, beginning of year |
|
187.1 |
|
|
|
193.3 |
|
Cash and cash equivalents, end of year |
$ |
232.7 |
|
|
$ |
187.1 |
|
CONSOLIDATED RATE ANALYSIS |
|||||||
(Unaudited) |
|||||||
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Twelve Months Ended |
||||
|
|
|
|
||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Gross margin |
35.8 % |
|
34.1 % |
|
35.5 % |
|
33.8 % |
Operating expenses |
20.2 % |
|
20.4 % |
|
20.4 % |
|
19.8 % |
Operating margin |
15.6 % |
|
13.7 % |
|
15.2 % |
|
14.0 % |
Other expense (income), net |
0.2 % |
|
(0.2) % |
|
(0.3) % |
|
(0.2) % |
Depreciation and amortization |
2.7 % |
|
2.9 % |
|
2.7 % |
|
2.7 % |
EBITDA |
18.1 % |
|
16.8 % |
|
18.3 % |
|
16.9 % |
Effective tax rate |
21.3 % |
|
21.7 % |
|
22.7 % |
|
23.4 % |
Earnings before income taxes - Mobile Solutions |
18.3 % |
|
16.2 % |
|
18.0 % |
|
15.2 % |
Earnings before income taxes - Industrial Solutions |
20.1 % |
|
19.2 % |
|
18.6 % |
|
18.4 % |
Earnings (loss) before income taxes - Life Sciences |
(1.2) % |
|
(12.4) % |
|
(3.9) % |
|
4.1 % |
Cash conversion ratio |
97.4 % |
|
179.9 % |
|
98.4 % |
|
118.8 % |
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Twelve Months Ended |
||||
|
|
|
|
||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Adjusted Rates |
|
|
|
|
|
|
|
Gross margin |
36.2 % |
|
34.3 % |
|
35.6 % |
|
33.9 % |
Operating expenses |
19.9 % |
|
20.0 % |
|
20.3 % |
|
19.3 % |
Operating margin |
16.3 % |
|
14.3 % |
|
15.4 % |
|
14.6 % |
Other expense (income), net |
0.2 % |
|
(0.2) % |
|
(0.3) % |
|
(0.2) % |
Depreciation and amortization |
2.7 % |
|
2.9 % |
|
2.7 % |
|
2.7 % |
EBITDA |
18.8 % |
|
17.3 % |
|
18.4 % |
|
17.5 % |
Effective tax rate |
21.5 % |
|
21.8 % |
|
22.7 % |
|
23.5 % |
Earnings before income taxes - Mobile Solutions |
18.3 % |
|
16.2 % |
|
18.0 % |
|
15.2 % |
Earnings before income taxes - Industrial Solutions |
20.1 % |
|
19.2 % |
|
18.6 % |
|
18.4 % |
Earnings (loss) before income taxes - Life Sciences |
(1.2) % |
|
(12.4) % |
|
(3.9) % |
|
4.1 % |
Cash conversion ratio |
93.3 % |
|
173.0 % |
|
97.3 % |
|
113.6 % |
Note: Rate analysis metrics are computed by dividing the applicable amount by net sales, and cash conversion ratio reflects free cash flow divided by net earnings. Adjusted rates exclude charges related to restructuring in fiscal 2024, and the organizational redesign and costs associated with exiting a lower-margin customer program in fiscal 2023. Adjusted rates are non-GAAP measures; see the Reconciliation of Non-GAAP Financial Measures schedule for additional information. |
SEGMENT DETAIL |
|||||||||||||||||||||
(In millions) |
|||||||||||||||||||||
(Unaudited) |
|||||||||||||||||||||
|
|
|
|
||||||||||||||||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
Change |
|
|
2024 |
|
|
|
2023 |
|
|
Change |
||
Net sales |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Off-Road |
$ |
89.9 |
|
|
$ |
103.4 |
|
|
(13.0 |
)% |
|
$ |
380.8 |
|
|
$ |
428.7 |
|
|
(11.2 |
)% |
On-Road |
|
32.9 |
|
|
|
37.3 |
|
|
(11.8 |
) |
|
|
139.8 |
|
|
|
145.8 |
|
|
(4.1 |
) |
Aftermarket |
|
452.5 |
|
|
|
401.8 |
|
|
12.6 |
|
|
|
1,730.2 |
|
|
|
1,600.3 |
|
|
8.1 |
|
Total Mobile Solutions segment |
|
575.3 |
|
|
|
542.5 |
|
|
6.1 |
|
|
|
2,250.8 |
|
|
|
2,174.8 |
|
|
3.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Industrial Filtration Solutions |
|
237.4 |
|
|
|
241.0 |
|
|
(1.5 |
) |
|
|
901.1 |
|
|
|
872.2 |
|
|
3.3 |
|
Aerospace and Defense |
|
50.4 |
|
|
|
36.1 |
|
|
39.7 |
|
|
|
165.4 |
|
|
|
142.5 |
|
|
16.0 |
|
Total Industrial Solutions segment |
|
287.8 |
|
|
|
277.1 |
|
|
3.9 |
|
|
|
1,066.5 |
|
|
|
1,014.7 |
|
|
5.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Total Life Sciences segment |
|
72.3 |
|
|
|
59.9 |
|
|
20.7 |
|
|
|
269.0 |
|
|
|
241.3 |
|
|
11.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
$ |
935.4 |
|
|
$ |
879.5 |
|
|
6.4 |
% |
|
$ |
3,586.3 |
|
|
$ |
3,430.8 |
|
|
4.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Earnings (loss) before income taxes |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Mobile Solutions segment |
$ |
105.2 |
|
|
$ |
88.1 |
|
|
19.4 |
% |
|
$ |
404.5 |
|
|
$ |
330.4 |
|
|
22.4 |
% |
Industrial Solutions segment |
|
57.8 |
|
|
|
53.2 |
|
|
8.6 |
|
|
|
198.8 |
|
|
|
186.2 |
|
|
6.8 |
|
Life Sciences segment |
|
(0.9 |
) |
|
|
(7.4 |
) |
|
87.8 |
|
|
|
(10.4 |
) |
|
|
9.9 |
|
|
NM |
|
Corporate and unallocated |
|
(22.7 |
) |
|
|
(16.6 |
) |
|
(36.7 |
) |
|
|
(57.6 |
) |
|
|
(57.8 |
) |
|
0.3 |
|
|
$ |
139.4 |
|
|
$ |
117.3 |
|
|
18.9 |
% |
|
$ |
535.3 |
|
|
$ |
468.7 |
|
|
14.2 |
% |
Earnings (loss) before income taxes percentage |
|
|
|
|
|
|
|
|
|
|
|
||||||
Mobile Solutions segment |
18.3 |
% |
|
16.2 |
% |
|
2.1 |
% |
|
18.0 |
% |
|
15.2 |
% |
|
2.8 |
% |
Industrial Solutions segment |
20.1 |
% |
|
19.2 |
% |
|
0.9 |
% |
|
18.6 |
% |
|
18.4 |
% |
|
0.2 |
% |
Life Sciences segment |
(1.2 |
)% |
|
(12.4 |
)% |
|
11.2 |
% |
|
(3.9 |
)% |
|
4.1 |
% |
|
(8.0 |
)% |
Note: Earnings (loss) before income taxes percentage is calculated by dividing earnings before income taxes by net sales. Amounts may not foot due to rounding. |
NM = Not meaningful |
SEGMENT SALES PERCENT CHANGE FROM PRIOR PERIODS BY GEOGRAPHY, AS REPORTED |
||||||||||||||
(Unaudited) |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Three Months Ended |
|||||||||||||
|
TOTAL |
|
|
|
EMEA(3) |
|
APAC(4) |
|
LATAM (5) |
|||||
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Off-Road |
(13.0 |
)% |
|
13.9 |
% |
|
(30.7 |
)% |
|
(18.2 |
)% |
|
(32.6 |
)% |
On-Road |
(11.8 |
) |
|
(6.4 |
) |
|
1.1 |
|
|
(34.1 |
) |
|
47.0 |
|
Aftermarket |
12.6 |
|
|
15.9 |
|
|
7.4 |
|
|
3.5 |
|
|
21.6 |
|
Total Mobile Solutions segment |
6.1 |
|
|
13.5 |
|
|
(4.0 |
) |
|
(4.9 |
) |
|
18.8 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Industrial Filtration Solutions |
(1.5 |
) |
|
1.4 |
|
|
(8.2 |
) |
|
0.5 |
|
|
22.7 |
|
Aerospace and Defense |
39.7 |
|
|
51.8 |
|
|
13.0 |
|
|
18.3 |
|
|
|
|
Total Industrial Solutions segment |
3.9 |
|
|
10.8 |
|
|
(5.9 |
) |
|
0.8 |
|
|
22.7 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|||||
Total Life Sciences segment |
20.7 |
|
|
(14.7 |
) |
|
17.4 |
|
|
47.0 |
|
|
36.8 |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
6.4 |
% |
|
11.5 |
% |
|
(2.8 |
)% |
|
3.1 |
% |
|
19.5 |
% |
|
|
|
|
|
|
|
|
|
|
|||||
|
Twelve Months Ended |
|||||||||||||
|
TOTAL |
|
|
|
EMEA |
|
APAC |
|
LATAM |
|||||
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Off-Road |
(11.2 |
)% |
|
4.4 |
% |
|
(16.9 |
)% |
|
(24.3 |
)% |
|
(25.9 |
)% |
On-Road |
(4.1 |
) |
|
(1.6 |
) |
|
13.4 |
|
|
(18.8 |
) |
|
15.3 |
|
Aftermarket |
8.1 |
|
|
10.5 |
|
|
2.8 |
|
|
5.1 |
|
|
12.5 |
|
Total Mobile Solutions segment |
3.5 |
|
|
8.4 |
|
|
(2.7 |
) |
|
(3.8 |
) |
|
10.2 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Industrial Filtration Solutions |
3.3 |
|
|
6.6 |
|
|
0.2 |
|
|
(4.2 |
) |
|
16.2 |
|
Aerospace and Defense |
16.0 |
|
|
19.9 |
|
|
4.7 |
|
|
49.0 |
|
|
|
|
Total Industrial Solutions segment |
5.1 |
|
|
9.2 |
|
|
0.7 |
|
|
(3.4 |
) |
|
16.2 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|||||
Total Life Sciences segment |
11.5 |
|
|
(9.4 |
) |
|
19.6 |
|
|
13.0 |
|
|
35.4 |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
4.5 |
% |
|
8.1 |
% |
|
0.5 |
% |
|
(1.2 |
)% |
|
11.2 |
% |
Note: Amounts may not foot due to rounding. |
(1) |
SEGMENT SALES PERCENT CHANGE FROM PRIOR PERIODS BY GEOGRAPHY, CONSTANT CURRENCY |
||||||||||||||
(Unaudited) |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Three Months Ended |
|||||||||||||
|
TOTAL |
|
|
|
EMEA |
|
APAC |
|
LATAM |
|||||
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Off-Road |
(11.7 |
)% |
|
13.9 |
% |
|
(30.0 |
)% |
|
(13.8 |
)% |
|
(30.5 |
)% |
On-Road |
(9.7 |
) |
|
(6.4 |
) |
|
3.4 |
|
|
(29.1 |
) |
|
57.3 |
|
Aftermarket |
13.9 |
|
|
15.9 |
|
|
8.5 |
|
|
6.9 |
|
|
24.0 |
|
Total Mobile Solutions segment |
7.4 |
|
|
13.5 |
|
|
(3.0 |
) |
|
(1.1 |
) |
|
21.2 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Industrial Filtration Solutions |
(0.8 |
) |
|
1.4 |
|
|
(7.7 |
) |
|
3.8 |
|
|
25.2 |
|
Aerospace and Defense |
40.1 |
|
|
51.8 |
|
|
14.1 |
|
|
22.6 |
|
|
|
|
Total Industrial Solutions segment |
4.6 |
|
|
10.8 |
|
|
(5.3 |
) |
|
4.2 |
|
|
25.2 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|||||
Total Life Sciences segment |
23.2 |
|
|
(14.7 |
) |
|
18.2 |
|
|
53.0 |
|
|
41.2 |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
7.6 |
% |
|
11.5 |
% |
|
(1.9 |
)% |
|
7.1 |
% |
|
21.9 |
% |
|
|
|
|
|
|
|
|
|
|
|||||
|
Twelve Months Ended |
|||||||||||||
|
TOTAL |
|
|
|
EMEA |
|
APAC |
|
LATAM |
|||||
Mobile Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Off-Road |
(11.3 |
)% |
|
4.4 |
% |
|
(19.1 |
)% |
|
(20.6 |
)% |
|
(26.4 |
)% |
On-Road |
(3.0 |
) |
|
(1.6 |
) |
|
12.3 |
|
|
(14.4 |
) |
|
15.9 |
|
Aftermarket |
8.2 |
|
|
10.5 |
|
|
1.3 |
|
|
8.6 |
|
|
11.8 |
|
Total Mobile Solutions segment |
3.6 |
|
|
8.4 |
|
|
(4.4 |
) |
|
(0.2 |
) |
|
9.6 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Industrial Solutions segment |
|
|
|
|
|
|
|
|
|
|||||
Industrial Filtration Solutions |
3.2 |
|
|
6.6 |
|
|
(1.6 |
) |
|
(1.0 |
) |
|
16.1 |
|
Aerospace and Defense |
15.5 |
|
|
19.9 |
|
|
2.4 |
|
|
53.5 |
|
|
(56.8 |
) |
Total Industrial Solutions segment |
4.9 |
|
|
9.2 |
|
|
(1.2 |
) |
|
(0.2 |
) |
|
16.1 |
|
|
|
|
|
|
|
|
|
|
|
|||||
Life Sciences segment |
|
|
|
|
|
|
|
|
|
|||||
Total Life Sciences segment |
11.7 |
|
|
(9.4 |
) |
|
16.7 |
|
|
16.6 |
|
|
35.3 |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
4.5 |
% |
|
8.1 |
% |
|
(1.4 |
)% |
|
2.3 |
% |
|
10.6 |
% |
Note: The constant currency presentation, which is a non-GAAP measure, excludes the impact of fluctuations in foreign currency exchange rates. The Company believes providing constant currency information provides valuable supplemental information regarding its results of operations. The Company calculates constant currency percentages by converting its current period local currency financial results using the prior period exchange rates and compares these adjusted amounts to its prior period reported results. Amounts may not foot due to rounding. |
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES |
|||||||||||||||
(In millions, except per share amounts) |
|||||||||||||||
(Unaudited) |
|||||||||||||||
|
|
|
|
||||||||||||
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
|
|
|
||||||||||||
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Net cash provided by operating activities |
$ |
126.0 |
|
|
$ |
190.8 |
|
|
$ |
492.5 |
|
|
$ |
544.5 |
|
Net capital expenditures |
|
(19.1 |
) |
|
|
(25.5 |
) |
|
|
(84.9 |
) |
|
|
(118.1 |
) |
Free cash flow |
$ |
106.9 |
|
|
$ |
165.4 |
|
|
$ |
407.6 |
|
|
$ |
426.3 |
|
|
|
|
|
|
|
|
|
||||||||
Net earnings |
$ |
109.7 |
|
|
$ |
91.9 |
|
|
$ |
414.0 |
|
|
$ |
358.8 |
|
Income taxes |
|
29.7 |
|
|
|
25.4 |
|
|
|
121.3 |
|
|
|
109.9 |
|
Interest expense |
|
5.3 |
|
|
|
4.9 |
|
|
|
21.4 |
|
|
|
19.2 |
|
Depreciation and amortization |
|
24.9 |
|
|
|
25.1 |
|
|
|
98.4 |
|
|
|
92.3 |
|
EBITDA |
$ |
169.6 |
|
|
$ |
147.3 |
|
|
$ |
655.1 |
|
|
$ |
580.2 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted net earnings |
$ |
114.5 |
|
|
$ |
95.6 |
|
|
$ |
418.8 |
|
|
$ |
375.2 |
|
Adjusted income taxes |
|
31.3 |
|
|
|
26.6 |
|
|
|
122.9 |
|
|
|
115.3 |
|
Interest expense |
|
5.3 |
|
|
|
4.9 |
|
|
|
21.4 |
|
|
|
19.2 |
|
Depreciation and amortization |
|
24.9 |
|
|
|
25.1 |
|
|
|
98.4 |
|
|
|
92.3 |
|
Adjusted EBITDA |
$ |
176.0 |
|
|
$ |
152.2 |
|
|
$ |
661.5 |
|
|
$ |
602.0 |
|
|
|
|
|
|
|
|
|
||||||||
Gross profit |
$ |
334.8 |
|
|
$ |
300.1 |
|
|
$ |
1,274.4 |
|
|
$ |
1,160.6 |
|
Restructuring and other charges |
|
3.8 |
|
|
|
1.4 |
|
|
|
3.8 |
|
|
|
2.9 |
|
Adjusted gross profit |
$ |
338.6 |
|
|
$ |
301.5 |
|
|
$ |
1,278.2 |
|
|
$ |
1,163.5 |
|
|
|
|
|
|
|
|
|
||||||||
Operating expense |
$ |
188.6 |
|
|
$ |
179.6 |
|
|
$ |
730.3 |
|
|
$ |
680.4 |
|
Restructuring and other charges |
|
(2.6 |
) |
|
|
(3.5 |
) |
|
|
(2.6 |
) |
|
|
(18.9 |
) |
Adjusted operating expense |
$ |
186.0 |
|
|
$ |
176.1 |
|
|
$ |
727.7 |
|
|
$ |
661.5 |
|
|
|
|
|
|
|
|
|
||||||||
Operating income |
$ |
146.2 |
|
|
$ |
120.5 |
|
|
$ |
544.1 |
|
|
$ |
480.2 |
|
Restructuring and other charges |
|
6.4 |
|
|
|
4.9 |
|
|
|
6.4 |
|
|
|
21.8 |
|
Adjusted operating income |
$ |
152.6 |
|
|
$ |
125.4 |
|
|
$ |
550.5 |
|
|
$ |
502.0 |
|
|
|
|
|
|
|
|
|
||||||||
Net earnings |
$ |
109.7 |
|
|
$ |
91.9 |
|
|
$ |
414.0 |
|
|
$ |
358.8 |
|
Restructuring and other charges, net of tax |
|
4.8 |
|
|
|
3.7 |
|
|
|
4.8 |
|
|
|
16.4 |
|
Adjusted net earnings |
$ |
114.5 |
|
|
$ |
95.6 |
|
|
$ |
418.8 |
|
|
$ |
375.2 |
|
|
|
|
|
|
|
|
|
||||||||
Diluted EPS |
$ |
0.90 |
|
|
$ |
0.75 |
|
|
$ |
3.38 |
|
|
$ |
2.90 |
|
Restructuring and other charges per share |
|
0.04 |
|
|
|
0.03 |
|
|
|
0.04 |
|
|
|
0.14 |
|
Adjusted diluted EPS |
$ |
0.94 |
|
|
$ |
0.78 |
|
|
$ |
3.42 |
|
|
$ |
3.04 |
|
2025 Adjusted EPS Guidance
A reconciliation of the Company’s fiscal 2025 adjusted EPS guidance to fiscal 2025 GAAP EPS guidance is not included in this release due to the number of variables in the projected GAAP EPS range and the Company’s current inability to reasonably quantify certain amounts, such as restructuring or other charges, that would be included in the GAAP measure or the individual adjustments for such reconciliation.
Note: Although free cash flow, EBITDA, adjusted EBITDA, adjusted gross profit, adjusted operating expense, adjusted operating income, adjusted income taxes, adjusted net earnings and adjusted diluted EPS are not measures of financial performance under GAAP, the Company believes they are useful in understanding its financial results. Free cash flow is a commonly used measure of a company’s ability to generate cash in excess of its operating needs. EBITDA is a commonly used measure of operating earnings less non-cash expenses. The adjusted basis presentation excludes the impact of certain matters not related to the Company’s ongoing operations. Management believes that the adjusted basis presentation reflects management’s performance in operating the Company and provides a meaningful representation of the performance of the Company’s core business and is useful to understanding its financial results. A shortcoming of these financial measures is that they do not reflect the Company’s actual results under GAAP. Management does not intend these items to be considered in isolation or as a substitute for the related GAAP measures. Amounts may not foot due to rounding.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240828284425/en/
Sarika.Dhadwal@Donaldson.com
Source: